Synthesis, characterization, and cytotoxicity evaluation of high-magnetization multifunctional nanoclusters
Source abstract
Abstract
The paper presents the synthesis, characterization, and in vitro cytotoxicity tests of Fe3O4 magnetic nanoclusters coated with ethylenediaminetetraacetic acid disodium salt (EDTA). Electron microscopy analysis (SEM) evidences that magnetite nanoparticles are closely packed into the clusters stabilized with EDTA with well-defined near spherical shapes and sizes in the range 100–200 nm. From XRD measurements, we determined the mean size of the crystallites inside the magnetic cluster about 36 nm. The saturation magnetization determined for the magnetic clusters stabilized with EDTA has high value, about 81.7 emu/g at 300 K. X-ray photoelectron spectroscopy has been used to determine both the elemental and chemical structure of the magnetic cluster surface. In vitro studies have shown that the magnetic clusters at low doses did not induce toxicity on human umbilical vein endothelial cells or lesions of the cell membrane. In contrast, at high doses, the magnetic clusters increased the lipid peroxidation and reduced the leakage of a cytoplasmic enzyme, lactate dehydrogenase (LDH), in parallel with increasing the antioxidant defense.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoparticles: synthesis and applications · Iron oxide chemistry and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P et al (2003) Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228:777–78810.1148/radiol.2283020872 ↗
2. Apopa PL, Qian Y, Shao R, Guo NL, Schwegler-Berry D, Pacurari M (2009) Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. Part FibreToxicol 6:1. doi: 10.1186/1743-8977-6-110.1186/1743-8977-6-1 ↗
3. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA (2005) A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. NMR Biomed 18:383–38910.1002/nbm.970 ↗
4. Azizi K, Ghonchepour E, Karimi M, Heydari A (2015) Encapsulation of Pd(II) into superparamagnetic nanoparticles grafted with EDTA and their catalytic activity towards reduction of nitroarenes and Suzuki–Miyaura coupling. Appl Organometal Chem 29:187–19410.1002/aoc.3258 ↗
5. Babes L, Denizot B, Tanguy G (1999) Synthesis of iron oxide nanoparticles used as MRI contrast agents: a parametric study. J Colloid Interface Sci 212:474–44810.1006/jcis.1998.6053 ↗
6. Berry CC, Wells S, Charles S, Curtis AS (2003) Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24:4551–455710.1016/S0142-9612(03)00237-0 ↗
7. Bigall NC, Wilhelm C, Beoutis ML, García-Hernandez M, Khan A, Giannini C et al (2013) Colloidal ordered assemblies in a polymer shell—a novel type of magnetic nanobeads for theranostic applications. Chem Mater 25:1055–106210.1021/cm3036746 ↗
8. Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK et al (2006) In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol 40:4374–438110.1021/es052069i ↗
9. Cengelli F, Maysinger D, Tschudi-Monnet F et al (2006) Interaction of functionalized superparamagnetic iron oxide nanoparticles with brain structures. J Pharmacol Exp Ther 318:108–11610.1124/jpet.106.101915 ↗
10. Chen L, Li J, Wang S, Lu W, Wu A, Choo J, Chen L (2014) FITC functionalized magnetic core-shell Fe3O4/Ag hybrid nanoparticle for selective determination of molecular biothiols. Sensors Actuators B Chem 193:857–86310.1016/j.snb.2013.12.053 ↗
11. Chen H, Xie Y, Kirillov AM, Liu L, Yu M, Liu W, Tang Y (2015) A ratiometric fluorescent nanoprobe based on terbium functionalized carbon dots for highly sensitive detection of an anthrax biomarker. Chem Commun 51:5036–503910.1039/C5CC00757G ↗
12. Conti M, Moran PC, Levillain P (1991) Improved fluorimetric determination of malondialdehyde. Clin Chem 37:1273–127510.1093/clinchem/37.7.1273 ↗
13. Corrias A, Mountjoy G, Loche D, Puntes V, Falqui A, Zanella M, Parak W, Casula MF (2009) Identifying spinel phases in nearly monodisperse iron oxide colloidal nanocrystal J. Phys Chem C 113:18667–1867510.1021/jp9047677 ↗
14. Day ES, Morton JG, West JL (2009) Nanoparticles for thermal cancer therapy. J Biomech Eng 131:07401
15. Gobbo OL, Sjaastad K, Radomski MW, Vokov Y, Prina-Mello A (2015) Magnetic nanoparticles in cancer theranostics. Theranostics 5:1249–126310.7150/thno.11544 ↗
16. Grosvenor AP, Kobe BA, Biesinger MC, McIntyre NS (2004) Investigation of multiplet splitting of Fe 2p XPS spectra and bonding in iron compounds. Surf. Interface Anal 36:1564–157410.1002/sia.1984 ↗
17. Gutiérrez L, Costo R, Grüttner C, Westphal F, Gehrke N, Heinke D et al (2015) Synthesis methods to prepare single- and multi-core iron oxide nanoparticles for biomedical applications. Dalt Trans 44:2943–295210.1039/C4DT03013C ↗
18. Heath EI, Infante J, Lewis LD et al (2013) A randomized, doubleblind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors. Cancer Chemother Pharmacol 71:565–57310.1007/s00280-012-2030-8 ↗
19. Ho CH, Tsai CP, Chung CC, Tsai CY, Chen FR, Lin HJ, Lai CH (2011) Shape-controlled growth and shape-dependent cation site occupancy of monodisperse Fe3O4 nanoparticles. Chem Mater 23:1753–176010.1021/cm102758u ↗
20. Ho AL, Grewal RK, Leboeuf R et al (2013) Selumetinibenhanced radioiodine uptake in advanced thyroid cancer. N Engl J Med 368:623–63210.1056/NEJMoa1209288 ↗
21. Ismael R, Hegg SM et al (2012) Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trial. Lancet Oncol 13:869–87810.1016/S1470-2045(12)70329-7 ↗
22. Ito A, Ino K, Hayashida, Kobayashi M, Matsunuma T, Kagami H, Ueda M, Honda H (2005) Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force. Tissue Eng 11:155310.1089/ten.2005.11.1553 ↗
23. Jiao PF, Zhou HY, Chen LX, Yan B (2011) Cancer-targeting multifunctionalized gold nanoparticles in imaging and therapy. Curr Med Chem 18:2086–210210.2174/092986711795656199 ↗
24. Kaittanis C, Naser SA, Perez JM (2007) One-step, nanoparticle-mediated bacterial detection with magnetic relaxation. Nano Lett 7:380–38310.1021/nl062553z ↗
25. Krieg AF, Rosenblum LJ, Henry JB (1967) Lactate dehydrogenase isoenzymes a comparison of pyruvate-to-lactate and lactate-to-pyruvate assays. Clin Chem 13:196–20310.1093/clinchem/13.3.196 ↗
26. Krishnan K (2010) Biomedical nanomagnetics: a spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans Magn 46:2523–255810.1109/TMAG.2010.2046907 ↗
27. Krukemeyer MG, Krenn V, Jakobs M, Wagner W (2012) Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver-magnetic nanoparticles in cancer treatment. J Surg Res 175:35–4310.1016/j.jss.2011.01.060 ↗
28. Lartigue L, Hugounenq P, Alloyeau D, Clarke SP, Lévy M, Bacri JC et al (2012) Cooperative organization in iron oxide multi-core nanoparticles potentiates their efficiency as heating mediators and MRI contrast agents. ACS Nano 6:10935–1094910.1021/nn304477s ↗
29. Li W, Xu LP, Zhao DIL et al (2013) Cytokine-induced killer cell therapy for advanced pancreatic adenocarcinoma: a case report and review of the literature. Oncol Lett 5:1427–142910.3892/ol.2013.1200 ↗
30. Liu Y, Chen M, Hao Y (2013) Study on the adsorption of Cu(II) by EDTA functionalized Fe3O4 magnetic nano-particles. Chem Eng J 218:46–5410.1016/j.cej.2012.12.027 ↗
31. Ma P, Luo Q, Chen J, Gan Y, Du J, Ding S, Xi Z, Yang X (2012) Intraperitoneal injection of magnetic Fe3O4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice. Int J Nanomedicine 7:4809–4818
32. Mahmoudi M, Shokrgozar MA, Sardari S, Moghadam MK, Vali H, Laurent S, Stroeve P (2011) Irreversible changes in protein conformation due to interaction with superparamagnetic iron oxide nanoparticles. Nanoscale 3:112710.1039/c1nr10326a ↗
33. Ming W, Zhang D, Zeng Y, Lingjie W, Liu X, Liu J (2015) Nanocluster of superparamagnetic iron oxide nanoparticles coated with poly(dopamine) for magnetic field-targeting, highly sensitive MRI and photothermal cancer therapy. Nanotechnology 26:11510210.1088/0957-4484/26/11/115102 ↗
34. Mu Q, Jiang G, Chen L, Zhou H, Fourches D, Tropsha A, Yan B (2014) Chemical basis of interactions between engineered nanoparticles and biological systems. Chem Rev 114:7740–778110.1021/cr400295a ↗
35. Mulens V, De La Torre A, Marinello P et al (2010) Immunogenicity and safety of a NeuGcGM3 based cancer vaccine: results from a controlled study in metastatic breast cancer patients. Human Vaccines 6:736–74410.4161/hv.6.9.12571 ↗
36. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM et al (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090–209310.1126/science.1104742 ↗
37. Paquet C, De Haan HW, Leek DM, Lin HY, Xiang B, Tian G et al (2011) Clusters of superparamagnetic iron oxide nanoparticles encapsulated in a hydrogel: a particle architecture generating a synergistic enhancement of the T 2 relaxation. ACS Nano 5:3104–311210.1021/nn2002272 ↗
38. Pereira ALC, Berrocal GJP, Marchetti SG, Alexilda AA, Souza O, Rangel MC (2008) A comparison between the precipitation and impregnation methods for water gas shift catalysts. J Mol Catal A Chem 281:66–7210.1016/j.molcata.2007.07.042 ↗
39. Poulin S, Franca R, Moreau-Belanger L, Sacher E (2010) Confirmation of X-ray photoelectron spectroscopy peak attributions of nanoparticulate iron oxides using symmetric peak component line shapes. J Phys Chem C 114:10711–1071810.1021/jp100964x ↗
40. Sadeghiani N, Barbosa LS, Silva LP, Azevedo RB, Morais PC, Lacava ZGM (2005) Genotoxicity and inflammatory investigation in mice treated with magnetite nanoparticles surface coated with polyaspartic acid. J Magnetism Magnetic Materials 289:466–46810.1016/j.jmmm.2004.11.131 ↗
41. Simioni AR, Martins OP, Lacava ZG, Azevedo RB, Lima EC, Lacava BM, Morais PC, Tedesco AC (2006) Cell toxicity studies of albumin-based nanosized magnetic beads. J Nanosci Nanotechnol 6:2413–241510.1166/jnn.2006.511 ↗
42. Soenen SJ, Illyes E, Vercauteren D, Braeckmans K, Majer Z, De Smedt SC et al (2009) The role of nanoparticle concentration-dependent induction of cellular stress in the internalization of non-toxic cationic magnetoliposomes. Biomaterials 30:6803–681310.1016/j.biomaterials.2009.08.050 ↗
43. Song M, Moon WK, Kim Y, Lim D, Song IC, Yoon BW (2008) Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO. Korean J Radiol 8(5):365–37110.3348/kjr.2007.8.5.365 ↗
44. Stroh A, Zimmer C, Gutzeit C, Jakstadt M, Marschinke F, Jung T et al (2004) Iron oxide particles for molecular magnetic resonance imaging cause transient oxidative stress in rat macrophages. Free RadicBiol Med 36:976–98410.1016/j.freeradbiomed.2004.01.016 ↗
45. Sun C, Lee JSH, Zhang M (2008) Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Del Rev 60:1252–121210.1016/j.addr.2008.03.018 ↗
46. Tielen R, Verhoef C, Coevorden F et al (2013) Surgical treatment of locally advanced, non-metastatic, gastrointestinal stromal tumours after treatment with imatinib. Eur J Surg Oncol 39:150–15510.1016/j.ejso.2012.09.004 ↗
47. Toyokuni S (2002) Iron and carcinogenesis: from Fenton reaction to target genes. Redox Rep 7:189–19710.1179/135100002125000596 ↗
48. Vasir JK, Labhasetwar V (2008) Quantification of the force of nanoparticle-cell membrane interactions and its influence on intracellular trafficking of nanoparticles. Biomaterials 29:4244–425210.1016/j.biomaterials.2008.07.020 ↗
49. Vergun L, Klimchuk DA, Gorbik PP, Bondar LA, Perekhristenko PM (2009) Synthesis of immunomagnetic sorbents for separation of hepatitis B and C viruses. Mikrobiol Z 71:65–71
50. Vinayak S, Carlson RW (2013) mTOR inhibitors in the treatment of breast cancer. Oncology 27:38–44
51. Vinod TP, Chang JH, Kim J, Rhee SW (2008) Self-assembly and photopolymerization of diacetylene molecules on surface of magnetite nanoparticles. Bull Kor Chem Soc 29:799–80410.5012/bkcs.2008.29.4.799 ↗
52. Wang M, Wang N, Tang H, Cao M, She Y, Zhu L (2012) Surface modification of nano-Fe3O4 with EDTA and its use in H2O2 activation for removing organic pollutants. Catal Sci Technol 2:187–19410.1039/C1CY00260K ↗
53. Warner CL, Addleman RS, Cinson AD, Droubay TC, Engelhard MH, Nash MA, Yantasee W, Warner MG (2010) High-performance, superparamagnetic, nanoparticle-based heavy metal sorbents for removal of contaminants from natural waters. ChemSusChem 3:749–75710.1002/cssc.201000027 ↗
54. Welsh JW, Komaki R, Amini A et al (2013) Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer. J Clin Oncol 31:895–90210.1200/JCO.2011.40.1174 ↗
55. Xu F, Cheng C, Chen DX, Gu H (2012) Magnetite nanocrystal clusters with ultra-high sensitivity in magnetic resonance imaging. ChemPhysChem 13:336–34110.1002/cphc.201100548 ↗
56. Yamashita T, Hayes P (2008) Analysis of XPS spectra of Fe2+ and Fe3+ ions in oxide materials. Appl Surf Sci 254:2441–244910.1016/j.apsusc.2007.09.063 ↗
57. Yang J, Zeng Q, Peng L, Lei M, Song H, Tie B, Gu J (2013) La-EDTA coated Fe3O4 nanomaterial: preparation and application in removal of phosphate from water. J Environ Sci 25:413–41810.1016/S1001-0742(12)60014-X ↗